James Empfield
Corporate Officer/Principal bei XENON PHARMACEUTICALS INC.
Vermögen: 430 500 $ am 31.03.2024
Profil
James R.
Empfield is currently the Secretary & Director and Executive Vice President-Drug Discovery at Xenon Pharmaceuticals USA, Inc. and Xenon Pharmaceuticals, Inc. respectively.
He was previously the Director-CNS Chemistry Department at AstraZeneca Pharmaceuticals LP and Head-Research at Vertex Pharmaceuticals, Inc. He holds a doctorate from the University of Pennsylvania, a graduate degree from Bucknell University, and an undergraduate degree from Lebanon Valley College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 11.03.2024 | 10 000 ( 0,01% ) | 430 500 $ | 31.03.2024 |
Aktive Positionen von James Empfield
| Unternehmen | Position | Beginn |
|---|---|---|
| XENON PHARMACEUTICALS INC. | Corporate Officer/Principal | 01.02.2016 |
Xenon Pharmaceuticals USA, Inc.
 Xenon Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Xenon Pharmaceuticals USA, Inc. develops clinical-stage biopharmaceutical products. The company is headquartered in Boston, PA. | Director/Board Member | - |
Ehemalige bekannte Positionen von James Empfield
| Unternehmen | Position | Ende |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01.08.2015 |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Corporate Officer/Principal | 01.01.2006 |
Ausbildung von James Empfield
| University of Pennsylvania | Doctorate Degree |
| Bucknell University | Graduate Degree |
| Lebanon Valley College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| XENON PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
Xenon Pharmaceuticals USA, Inc.
Xenon Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Xenon Pharmaceuticals USA, Inc. develops clinical-stage biopharmaceutical products. The company is headquartered in Boston, PA. | Health Technology |
